| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |